# POTASSIUM PHOSPHATES
> **ANDA216344** · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2023-10-10
## Drug
- **FDA Application Number:** ANDA216344
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** POTASSIUM PHOSPHATES
- **Generic name:** POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC INJECTION,
- **Active ingredients:** POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** AMNEAL
- **Manufacturer:** Amneal Pharmaceuticals Private Limited
- **First approval:** 2023-10-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216344)
---
*MORVS · CC0 1.0*